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Effect of leukocyte depletion on glomerular dynamics during acute
glomerular immune injury. Large doses of anti-glomerular basement
membrane antibody (AGBM-Ab) have been shown consistently to
decrease both single nephron filtration rate (SNGFR) and the glomer-
ular ultrafiltration coefficient (LpA) within 60 mm of administration of
the antibody. Both the decrease in SNGFR and LpA may be the result
of infiltration of leukocytes blocking capillary loops and/or endothelial
cell separation from the glomerular basement membrane through
leukocyte dependent activated cytotoxic products or by mechanisms
associated with leukocyte activation and infiltration. Administration of
2.5 tg/g body wt AGBM-Ab was performed in 10 control Munich-
Wistar rats and in six Munich-Wistar rats in which 3 to 5 days prior to
micropuncture experiments the rats were splenectomized and then
irradiated to produce leukocyte depletion. Micropuncture measure-
ments were performed in a condition of plasma volume expansion both
prior to and after AGBM-Ab administration. In the control group,
SNGFR decreased from 64 3 to 48 2 nI/mm g kidney wt after
AGBM-Ab administration due to a decrease in LpA from 0.13 to 0.06 nI
• sec mm Hg1 • g kidney wt. This decrease in either SNGFR or
LpA did not occur in the leukocyte depleted group. Linear deposits of
IgG and C3 were similar in both groups. Polymorphonuclear leukocytes
were significantly decreased in glomerulus from 7.4 0.7 in control vs.
0.7 0.3 in leukocyte depletion (P < 0.01). There was no difference in
glomerular dynamics between controls and leukocyte depleted rats
prior to AGBM-Ab administration. Therefore, reduction of leukocytes
with irradiation prevented the decrease in LpA and SNGFR with
AGBM-Ab administration, suggesting a role for leukocytes in mediating
the LpA reduction.
Effet d'une déplétion leucocytaire sur Ia dynamique glomérutaire tars
d'une atteinte glomerulaire aigue immune. 11 a constamment été montré
que de grandes quantités d'anticorps anti-membrane basale
glomérulaire (AGBM-Ab) diminuent le debit glomerulaire individuel
(SNGFR) et le coefficient d'ultrafiltration glomérulaire (LpA) au bout
de 60 mm après administration de l'anticorps. La diminution de SNGFR
et LpA pourraient résulter d'une infiltration de leucocytes bloquant les
anses capillaires et/ou d'une separation des cellules endothéliales a
partir de Ia membrane basale glomérulaire par des produits cytoxiques
activCs dépendant des leucocytes, ou par des mécanismes associés
d'une activation et une infiltration leucocytaire. L'administration de 2,5
g/g poids corps d'AGBM-Ab a été effectuée chez 10 rats Munich-
Wistar contrôles et chez six rats Munich-Wistar chez qui 3 a 5 jours
avant des experiences de microponction une splenectomie avait eté
faite, suivie d'une irradiation pour entratner une depletion leucocytaire.
Les mesures de microponction ont été faites en condition d'expansion
volumique avant et aprés administration d'AGBM-Ab. Dans Ic groupe
contrOle, SNGFR a diminué de 64 3 a 48 2 nI/mm g poids rein
après administration d'AGBM-Ab en raison d'une baisse de LpA de
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0,13 a 0,06 n1 sec' mm Hg' g poids rein'. Cette diminution de
SNGFR ou de LpA ne s'est pas produite dans le groupe déplétC en
leucocytes, Des dépôts Iinéaires d'IgG et de C3 dtaient semblables dans
les deux groupes. Les leucocytes polynucléaires étaient significative-
ment diminués dans les glomérules, de 7,4 0,7 chez les contrôles
contre 0,7 0,3 en déplétion leucocytaire (P < 0,01). Il n'y avait pas de
difference de dynamique glomerulaire entre les rats contrôles ou
déplétés en leucocytes avant administration d'AGBM-Ab. Ainsi, Ia
reduction des leucocytes par irradiation a prévenu la baisse de LpA et
de SNGFR par administration d'AGBM-Ab, suggérant un role des
leucocytes dans Ia reduction de LpA.
In previous laboratory studies [1—4] we have demonstrated
that nephron filtration rate (SNGFR) in rats decreased within 60
mm of administration of a large dose of complement fixing
anti-glomerular basement membrane antibody (AGBM-Ab).
We have ascertained also that the glomerular ultrafiltration
coefficient (LpA) for water and electrolytes is decreased con-
sistently during this period after AGBM-Ab administration
[1—4]. The reduction in SNGFR was due to both decreases in
LpA and nephron plasma flow (SNPF). In previous studies, we
have attempted to delineate the specific mechanisms affecting
nephron filtration by examining: the actions of complement
through complement depletion which ameliorated partially the
reduction in LpA and SNPF [2]; a variety of vasoactive
substances by inhibition of angiotensin II, a-adrenergic activity
[3]; and histamine activity [4], in which only an infusion of the
a-adrenergic antagonist, phentolamine, prevented the antibody
induced reductions in SNGFR by eliminating the renal vaso-
constriction and by ameliorating the reduction in LpA [31.
We have hypothesized that the reduction in the glomerular
ultrafiltration coefficient due to AGBM-Ab administration may
be the result of infiltration of leukocytes blocking capillary
loops and/or endothelial cell separation from the glomerular
basement membrane through leukocyte dependent activated
cytotoxic products or by leukocyte independent mechanisms.
Complement depletion prevented a considerable portion of the
reduction in LpA after administration of a large dose of AGBM-
Ab, and this effect was associated strongly with a reduction in
the accumulation of polymorphonuclear (PMN) leukocytes
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within the glomerular capillary. Data by Harlan et al using
endothelial cell cultures have shown that neutrophils also can
induce endothelial injury by endothelial cell lysis and cell
detachment [5], and we have observed separation of the
Leukocyte depletion during glomerular immune injury 29
endothelial cell from the underlying glomerular basement mem-
brane after AGBM-Ab, although we have observed some
endothelial detachment without PMNs adhering to the glomer-
ular capillary wall. If a major portion of the decrease in the
glomerular ultrafiltration coefficient, hence a reduction in neph-
ron filtration rate, is due to complement activation and the
associated adherence of leukocytes that in turn could plug
capillaries and injure the endothelial cells, then eliminating
leukocytes from the circulation should ameliorate this decrease
in LpA.
Therefore, we have examined the acute effects of AGBM-Ab
administration on the determinants of glomerular ultrafiltration
in a group of normal control rats and in a second group of rats
in which leukocyte depletion had been achieved by prior (3 to 5
days) whole body irradiation with shielding of the kidneys.
These studies demonstrate and reaffirm the critical role of
polymorphonuclear leukocytes in the early phases of acute
glomerular immune injury.
Methods
Experimental animals
The current studies were performed on Munich-Wistar rats
(180 to 290 g body wt), bred and maintained in a colony housed
at the Animal Research Facility at the San Diego Veterans
Administration Medical Center, San Diego, California, USA.
Preparation of AGBM-Ab
AGBM-Ab was produced by immunizing rabbits repeatedly
with 10 to 20 mg of rat glomerular basement membrane in
complete Freund's adjuvant. Rat glomerular basement mem-
brane was prepared by a modification of the method of
Krakower and Greenspon [6]. The attainment of nephrotoxic
levels of AGBM-Ab in rabbits was recognized when intrave-
nous injection of rabbit serum induced acute proteinuria in rats.
Then rabbit serum was collected, pooled, and absorbed with rat
plasma and peripheral blood cells, and the gamma globulin
fraction separated and concentrated by precipitation at a final
concentration of 50% saturated ammonium sulfate. The gamma
globulin fractions containing AGBM-Ab obtained by this pro-
cedure and normal rabbit gamma globulin fractions were pair
labeled with 1131 and J125 radioisotopes of iodine, using 100 ig of
each globulin fraction, and the amount of kidney-fixing anti-
body was quantitated by the pair-label isotope technique [7, 81.
This technique was used also to quantitate the effect of irradi-
ation of the rat on the binding of antibody.
Micropuncture studies evaluating glomerular dynamics before
and after AGBM-Ab
The micropuncture protocol used in this study was nearly
identical to that described in our previous studies on glomerular
immune injury [1-4]. Surgical preparation was described previ-
ously [1, 2, 9, 10], and all studies were paired with iso-oncotic
plasma expansion (2.5% body wt plus 1.25% body wt isotonic
NaCI—NaHCO3 solution infused intravenously over 60 mm) as
the control condition. A separate infusion of C'4—inulin dis-
solved in isotonic NaCI—NaHCO3 solution (1.5 ml/hr) was
begun at the time of plasma expansion and was delivered at
approximately 50 tCi/hr.
Control group 1. (N = 10)
After the equilibration of radioactive inulin (60 mm), initial
measurements were obtained of glomerular capillary,
Bowman's space, and efferent arteriolar hydrostatic pressures
(using a servonulling device [1, 9] with 1 to 3 m beveled tip
pipettes, and of SNGFR (N = 5), and 3 to 4 samples of efferent
arteriolar blood from star vessels [9, 10].
After completion of the first period measurements, a dose of
2.5 igIg body wt of AGBM-Ab was administered i.v. in the
larger gamma globulin fraction over a 5 mm period in a volume
of 1 ml of isotonic sodium chloride-sodium bicarbonate solu-
tion. Fifteen mm following termination of AGBM-Ab infusion,
all pressure, filtration rate, and efferent protein concentration
measurements were repeated and completed within 35 to 45
mm. In previous studies on the mechanism of glomerular
immune injury with AGBM-Ab, we determined that inulin
remains a valid marker of glomerular ultrafiltration after the
antibody is administered [1].
Leukocyte depletion, group 2. (N = 6)
Three to 5 days prior to the day of micropuncture, the rats
first were splenectomized and then irradiated at a dose of 1200
rads from a bi-directional cesium source. During the irradiation
procedure, the kidneys were shielded by a lead ring approxi-
mately 3 cm thick, with a width of 3 cm encircling the rat. This
shielding to the kidney area was determined to be 85 to 90%
effective, measured by dosimeters such that the average kidney
dose was 150 rads. Rats with total white blood counts of less
than 500/mm3 were used in this study. (Not all rats achieved this
criteria and therefore were not used.) Also, some animals
exhibited hypoproteinemia, and only rats in which systemic
protein concentrations were greater than 5.5 g% (measured by
refractometer on a tail vein sample) on the day of the study
were used. Surgical preparation, inulin equilibration, and iso-
oncotic plasma expansion were identical to the control groups.
After completion of the first period of measurements, AGBM-
Ab was administered using the same protocol as in the control
group, followed by a second period during which all pressures,
filtration rate, and efferent protein measurements were repeated
and completed within 35 to 45 mm.
Analytic methods
Protein concentrations in systemic and efferent peritubular
blood samples were measured by a microadaptation [11] of the
Lowry protein method [12]. SNGFR, GFR, SNPF, SNBF, and
urine and plasma sodium and potassium concentrations were
determined as described previously [1—4, 10].
Morphologic studies and assessment of a radiation protocol
on parameters of inflammation
Tissue specimens for histologic, immunofluorescence, and
electron microscopic studies were obtained from both kidneys
at the termination of the study and processed as described
previously [1-4]. The mean polymorphonuclearleukocyte (PMN)
count per glomerulus was determined by light microscopy in 20
glomeruli from each kidney of each rat. The degree of encroach-
ment on the lumen of the glomerular capillary that was related
in part to endothelial abnormalities as well as inflammatory cells
(predominantly PMNs) was estimated from the light micro-
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Table 1. Effect of splenectomy and irradiation on white blood cell count (WBC), polymorphonuclear leukocyte (PMN) attachment, and
antiglomerular basement membrane antibody (AGBM-Ab) uptake
Control Irradiation
WBC before AGBM-Ab administration 7100 600 160 60 cells/mm3*
WBC prior to AGBM-Ab administration and after plasma volume expansion 14400 1000 170 70 cells/mm3*
WBC post-AGBM-Ab administration 9400 1200 70 30 cells/mm3*
PMN in blood 1800 300 12 6 cells/mm3*
PMN per glomerulus 7.4 0.7 0.7 0.3 cells/glomerulus*
AGBM-Ab uptake 0.326 0.009 0.333 0.004 jgIg kidney wt
*p < 0.01 compared to control.
scopic appearance. Endothelial abnormalities, foot process
fusion, and inflammatory cells approximated to the GBM were
evaluated by electron microscopy, as described previously [2J.
Controls included kidneys from rats splenectomized and irradi-
ated but not given AGBM-Ab (7 rats) and rats irradiated with
150 rads to the kidney area with the remainder of the body
shielded (2 rats).
Paired label isotope measurements were conducted to deter-
mine if the splenectomy and irradiation procedures influenced
the fixation of AGBM-Ab and thus changed the phlogogenic
stimulus. The total serum complement level was evaluated as
the CH50 [2, 3].
Calculations
Superficial nephron filtration fraction, nephron plasma flow
(SNPF), afferent arteriolar resistance (AR), efferent arteriolar
resistance (ER), and oncotic pressure (IT) from protein concen-
trations (C) were calculated as described previously [9, 10]. The
four determinants of ultrafiltration (SNGFR), namely, hydro-
static pressure gradient acting across the glomerular membrane
(AP), systemic oncotic pressure (IrA), the LpA, and SNPF
interrelate in the following manner: Because zP PG — PBS,
where G is the directly measured glomerular capillary hydro-
static pressure and BS is the hydrostatic pressure in Bowman's
space. The effective filtration pressure (EFP) can be defined as
follows:
EFP = zP — IT
where IT is the oncotic pressure in the glomerular capillary.
Oncotic pressures of systemic protein samples (CA) and efferent
arteriolar samples (CE) were determined by the following
relationship:
= l.74C + 0.28C2
which is a simplification by best fit analysis by least squares
between 4 and 10 g/dl of the empirical relationship defined by
Landis and Pappenheimer [13] where:
IT 2.IC + 0.l6C2 + 0.009C3
As a consequence of glomerular ultrafiltration, i rises along
the length of the glomerular capillary (x*) as a result of the
increase in protein concentration (C). The mean EFP (EFP) is
defined as follows:
EFP (P —
Changes in SNPF modify the PP profile along x' by
affecting the rate at which protein is concentrated and the rate
of rise in IT along x*. Therefore the SNGFR can be defined as
follows:
SNGFR = LpA x
where LpA is the glomerular ultrafiltration coefficient and
which in turn is a product of the hydraulic conductivity (Lp) of
the glomerular membrane and A, the total filtering surface area
of the glomerular capillaries.
Statistical analysis
The significance of data between periods before and after
AGBM-Ab administration in the two groups was determined by
two-way analysis of variance and by Student's t test, where
appropriate [14, 151. All data and error estimates are given as
mean SEM.
Results
Effects of irradiation on white blood cell count,
polymorphonuclear leukocyte count, AGBM-Ab uptake, and
complement binding
Circulating white blood cells (WBC) were significantly re-
duced in the irradiated group compared to control rats (Table
1). Prior to the plasma expansion protocol, the WBC count in
the control group was decreased markedly in the irradiated rats
(Table 1). After the plasma volume expansion, WBC increased
significantly to 14400 1000 cells/mm3 (P < 0.01) in the control
group (Table 1). WBC counts remained unchanged at 170 70
cells/mm3 in the irradiated group (Table 1). The PMNs were
affected also by irradiation in a similar fashion (Table 1). Both
the WBC counts and PMN counts in the control group are
similar to values reported in our previous studies [1—4]. The
splenectomy and irradiation treatment was effective in reducing
circulating WBC and PMN counts, as demonstrated by the
above data and that in Table 1.
In another group of six rats, of which three were splenectom-
ized and irradiated, paired labeled uptake studies of AGBM-Ab
were performed, and there was no significant difference in renal
AGBM-Ab uptake between control and irradiated rats. The
irradiated rats exhibited a WBC count of 370 40 cells/mm3
and the mean antibody uptake was 0.333 .004 ixg/g kidney wt
compared to 0.326 .007 in the control group. There is no
indication that irradiation exerted an effect on the renal uptake
of AGBM-Ab.
Complement activity was measured in a separate group of
nine rats in which six underwent the irradiation protocol 3 to 5
days prior to testing. Complement activity was ascertained by
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Table 2. Effect of acute AGBM-Ab administration on glomerular dynamics in control and leukocyte depleted rats
AR ER LpA
GFR SNGFR SNPF
MAP
mm Hg
ml/min
g kidney wt
nl/min
g kidney wt
P0 PBS P HPE x
1O dynes
sec cm5
A E
mm Hg
EFP ni/sec mm
Hg
g kidney wtmm Hg
C 125 1.51 64 264 59 21 38 23 12 8 22 35 9 0.13
Control ±2 ±0.05 ±3 ±26 ±1 ±1 ±1 ±1 ±1 ±1 ±1 ±1 ±1 ±0.01
(N = 10) E 122
±2
l.29a
±0.08
48 224
±2 ±20
55
±1
isa 40
±1 ±1
21
±1
14 8
±2 ±1
2l
±1
31
±1
l4
±1
0.06
±0.01
C
Leukocyte
depleted E
(N—6)
108
±6
114
±6
1.53
±0.06
1.48
±0.06
59 227
±4 ±37
58 214
±2 ±17
57
±1
52
±2
21 36
±1 ±1
l7 34
±2 ±1
23
±1
25
±1
11 10
±1 ±2
14 7
±2 ±1
19
±1
19
±1
31
±1
31
±1
11
±2
9
±2
0.10
±0.02
0.13
±0.03
Abbreviations are: MAP, mean arterial pressure; GFR, glomerular filtration rate; SNGFR, single nephron glomerular filtration rate; SNPF,
single nephron plasma flow; PG, glomerular capillary hydrostatic pressure; PBS, hydrostatic pressure in Bowman's space; AP, glomerular
hydrostatic pressure; HPE, efferent hydrostatic pressure; AR, afferent arteriolar resistance; ER, efferent arteriolar resistance; irA, afferent system
capillary oncotic pressure; irE, efferent systemic capillary oncotic pressure; EFP, mean effective filtration pressure; LpA, glomerular ultrafiltration
coefficient; C, pre-AGBM-Ab administration period; E, post-AGBM-Ab administration period.
a Post-AGBM-Ab period significantly different from pre-AGBM-Ab period, P < 0.05.
CH50 levels to test the effect of irradiation on complement
levels. CH50 levels did not decrease after the irradiation proto-
col, indicating that the irradiated group of rats did not differ in
circulating complement levels from the controls prior to the
administration of AGBM-Ab.
Group 1: Effect of AGBM-Ab on glomerular dynamics in
control rats (N = 10)
The control studies were performed interspersed in time
sequence with the irradiated group. Whole kidney glomerular
filtration rate (GFR, left kidney) decreased from 1.51 ± 0.05 to
1.29 ± 0.08 mllmin g kidney wt after AGBM-Ab administration
in the control group (P < 0.05, Table 2). The AGBM-Ab
administration produced a similar and significant decrease in
SNGFR from 64 ± 3 to 48 ± 2 ni/mm g kidney wt (P < 0.01,
Table 2, Fig. 1). In this group, SNPF did not significantly
decrease as a result of AGBM-Ab administration (264 ± 26 to
224 ± 20 nllmin g kidney wt, NS, Table 2, Fig. 1). The
superficial nephron filtration fraction did not significantly de-
crease (0.25 ± .02 to 0.23 ± .02), but the numerical difference
did trend in that direction.
The hydrostatic pressure in Bowman's space (PBS) decreased
significantly from 21 ± 1 to 15 ± 1 mm Hg (P < 0.01, Table 2).
The glomerular capillary hydrostatic pressure (PG) also de-
creased significantly after AGBM-Ab administration from 59 ±
1 to 55 ± 1 mm Hg (P < 0.05). These changes resulted in a
small, but significant, increase in the glomerular hydrostatic
pressure gradient (zP) from 38 ± 1 to 40 ± 1 mm Hg (Table 2),
such that the effect of hydrostatic forces on SNGFR was
positive after AGBM-Ab administration. The mean efferent
hydrostatic pressure (HPE) remained unchanged (Table 2).
The afferent and efferent arteriolar resistances did not change
significantly after AGBM-Ab administration (Table 2), which
differs from our previous results [1—4], and this lack of vaso-
constriction was associated with a constancy in nephron blood
flow (Table 1). Therefore, the reduction in SNGFR produced by
the AGBM-Ab used in this study is not the result of arteriolar
vasoconstriction.
II
Systemic plasma protein concentration (CA) decreased
slightly but significantly from 6.3 ± 0.1 to 6.0 ± 0.1 g/dl (P <
0.01), as did the efferent arteriolar plasma protein concentration
(CE, 8.4 ± 0.2 to 7.7 ± 0.3 g/dl P < 0.01). These changes in
protein concentration were reflected in the respective oncotic
pressures (Table 2). The hematocrit increased significantly after
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Fig. 1. Effect of AGBM-Ab administration on single nephron filtration
rate (SNGFR) and single nephron flow (SNPF) in both control and
leukocyte depleted rats. AGBM-Ab administration significantly de-
creased SNGFR but did not decrease SNPF in the control group. In the
leukocyte depleted group, AGBM-Ab administration did not decrease
SNGFR, which resulted in a higher post-AGBM-Ab administration
SNGFR compared to the control group. The SNPF in the leukocyte
depleted group also did not decrease after AGBM-Ab administration.
Symbols: *D < 0.05 compared to first group. +P < 0.05 compared to
control group.
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AGBM-Ab administration from 43 1 to 46 1% (P < 0.02),
a finding that concurs with our most recent studies utilizing
AGBM-Ab.
The mean effective filtration pressure, EFP, increased sig-
nificantly from 9 ito 14 1 mm Hg (P < 0.01) after AGBM-
Ab administration, a finding similar to previous ones when
using this type of antibody [1—41. Efferent effective filtration
pressure (EFPE) increased also from 3 1 to 9 1 mm Hg (P
<0.01). Since there was a reduction in SNGFR and an increase
in after AGBM-Ab administration and EFPE remained
significantly positive, the only factor that could have caused the
reduction in filtration rate is the glomerular ultrafiltration coef-
ficient (LpA). The LpA was reduced to less than 50% of the
control value after AGBM-Ab administration (0.13 .01 to 0.06
.01 nl/sec mm Hg g kidney wt, P < 0.01, Table 2, Fig. 2).
This finding conforms also to previous ones [1—4].
Group 2: Effect of AGBM-Ab on glomerular dynamics in
leukocyte depleted rats (N = 6)
Whole kidney GFR (left kidney) did not change after AGBM-
Ab administration (1.53 .06 to 1.48 .06 mLlmin g kidney
wt, NS) and was not different from the GFR in group 1 control
period. AGBM-Ab administration did not produce a decrease in
SNGFR (59 4 to 58 2, NS, Table 2, Fig. 1) and these values
were not different from the control period group 1 rats (Table 1).
There was no decrease in SNPF following AGBM-Ab adminis-
tration, nor were these values different from values obtained in
group I (Table 2, Fig. 1). As expected from these data, the
single nephron filtration fraction remained constant (0.28 0.03
to 0.28 0.01) and was not different from the control period in
group 1.
There was a small but significant decrease in BS from 21
I to 17 2 mm Hg (P < 0.02, Table 1) after AGBM-Ab
administration, but these values did not differ from group 1
control PBS (21 1 mm Hg). G also decreased after AGBM-Ab
administration from 57 ito 52 2 mm Hg (P < 0.01, Table
1), but since the decrease in PG was paralleled essentially by the
decrease in P5, there was no significant alteration in P (36
1 to 34 1 mm Hg, NS). These parallel alterations in G and
PBS after AGBM-Ab administration did not change the net
Fig. 2. Effect of AGBM-Ab administration on the
glomerular ultrafiltration coefficient (LpA) in both
control and leukocyte depleted rats. AGBM-Ab ad-
ministration decreased LpA from 0.13 to 0.06 nI
sec' mm Hg-' g kidney wt' in the control group.
There was no decrease in LpA after AGBM-Ab
administration in the leukocyte depleted group of
rats, which provides evidence that this type of
leukocyte depletion protocol prevented totally the
expected decrease in LpA after AGBM-Ab adminis-
tration. Symbols are: *p < 0.05 compared to first
period. +P < 0.05 compared to control group.
hydrostatic forces for glomerular ultrafiltration (Table 1). There
was a significant difference in zW between groups 1 and 2 (40
1 vs. 34 1 mm Hg, P < 0.01, Table 2), indicating that
leukocyte depletion prevented the increase in zP following
AGBM-Ab administration. The efferent arteriolar hydrostatic
pressure remained unchanged after AGBM-Ab administration.
The AR and ER were not significantly altered by AGBM-Ab
administration (Table 2) and the arteriolar resistances were not
significantly different from the control group (group 1) despite
the significantly reduced mean arterial blood pressure (MAP)
prior to AGBM-Ab administration in the irradiated rats com-
pared to the control group (P < 0.02). Since AGBM-Ab had no
effect on arteriolar resistances in the leukocyte depleted rats,
the blood flow remained constant after antibody administration
(Table 2).
Systemic protein concentration remained constant after
AGBM-Ab administration at 5.7 0.2 g/dl. AGBM-Ab admin-
istration did not alter CE in leukocyte depleted rats, which
remained at a value of 7.9 0.2 g!dl in both periods. The
corresponding oncotic pressures did not change after AGBM-
Ab administration and are shown in Table 2. However, the
hematocrit increased slightly but significantly from 42 1 to 44
1% (P < 0.05) after AGBM-Ab administration, which paral-
leled the alteration in the hematocrit in group 1 rats.
EFP in leukocyte depleted rats did not significantly change
after AGBM-Ab administration, a response that was different
from the control group (Table 2). EFP in group 2 rats was
significantly lower than in group 1 (9 2 vs. 14 1 mm Hg, P
< 0.05) after AGBM-Ab administration, indicating that
leukocyte depletion prevented the increase in EFP due to
AGBM-Ab. Since there was no alteration in either SNGFR
or EFP after AGBM-Ab administration in leukocyte depleted
rats, LpA could not have been decreased by AGBM-Ab admin-
istration (0.10 0.02 vs. 0.13 0.03 ni/sec mm Hg• g kidney
wt, NS) (Fig. 2). The values for LpA measured in group 2 both
before and after AGBM-Ab administration were not different
from the control values measured in group 1 rats (0.13 0.01
ni/sec mm Hg g kidney wt, Fig. 2). These data provide clear
evidence that this type of leukocyte depletion protocol pre-
vented totally the expected decrease in the glomerular ultrafil-
tration coefficient after AGBM-Ab administration.
Control Leukocyte depleted
0.14
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0.10
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0.10
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Leukocyte depletion during glomerular immune injury 33
Immunomorphologic studies
The kidneys of both the control and leukocyte depleted rats
had similar patterns and intensities of rabbit IgG and rat C3
deposits in their glomeruli. This confirmed the paired label
uptake studies, which indicated that the leukocyte depletion
protocol had not affected AGBM-Ab uptake. The rabbit anti-rat
GBM IgG was present in a smooth linear pattern outlining the
GBM, as described previously for this model. The rat C3 was
less intense and more variable and irregular than the IgG, as
noted previously [21, but equal between the two groups and
correlated with the lack of effect of irradiation on serum
complement levels.
By light microscopy, the mean PMN count per glomerulus
was 7.4 0.7 in the control group vs. 0.7 0.3 in the leukocyte
depleted group (P < 0.01). In the control group, the degree of
apparent compromise of the glomerular capillary lumen by
infiltrating cells and irregularities of the endothelium was simi-
lar to that noted previously [21, with 25 to 50% of the glomerular
capillary ioops being involved. As would be expected, the
apparent compromise correlated with the numbers of PMNs
present. In the leukocyte depleted group, inflammatory cells
were absent generally; the degree of endothelial irregularity and
apparent compromise of the glomerular capillary lumen was
less severe than the AGBM-Ab controls, but difficult to quan-
tify.
The interpretation of electron microscopic findings was
clouded by variable abnormalities to morphologic appearance,
related in part to fixation and also, apparently, to radiation. The
control rats that were splenectomized and irradiated but not
given AGBM-Ab and rats given 150 rads to the kidneys with the
body shielded, when compared to unmanipulated counterparts,
had variable amounts of cellular debris in the glomerular
capillary lumens with some endothelial swelling, irregularity,
and minor separations, and focal areas of epithelial foot process
fusion. The striking difference between the AGBM-Ab control
group and the leukocyte depleted group was in the number of
inflammatory cells present, which were predominantly PMNs
with occasional mononuclear cells. The PMNs were associated
usually with the GBM, from which the endothelium often was
separated. The overall amount of endothelial separation varied
from 10 to 50%, as noted previously, but on the average was
somewhat less intensive than seen with other AGBM-Ab anti-
bodies used in this series of studies [1-4]. Focal foot process
fusion varied from 10 to 15%. In the leukocyte depleted group,
the intraluminal inflammatory cells frequently were absent, but
when found sometimes had a bizarre appearance. The degree of
endothelial separation and irregularity in the leukocyte depleted
rats was less than in the AGBM-Ab control rats, but exceeded,
at least in some areas, that found in the rats that had been
irradiated but not given AGBM-Ab.
Discussion
Studies we have performed in the rat have focused on the
events occurring within 1 hr of the administration of large doses
of AGBM-Ab [1—4]. Certain conclusions can be drawn from the
results regarding the mechanism of acute glomerular immune
injury after AGBM-Ab. First, the reduction in nephron filtration
rate that occurs is solely the consequence of two events: a
reduction in the glomerular ultrafiltration coefficient and a
decrease in nephron plasma flow as a result of renal vasocon-
striction. Second, prior complement depletion of the rat pre-
vented much of the reduction in LpA after AGBM-Ab and
eliminated also much of the renal vasoconstriction [2]. Third,
prior infusion of the a-adrenergic antagonist, phentolamine,
prevented the antibody induced reductions in SNGFR by
eliminating the renal vasoconstriction and by ameliorating the
observed reduction in LpA [31. Fourth, the reduction in LpA
after AGBM-Ab was attributable to both accumulation of
polymorphonuclear leukocytes within the glomerular capillary
and attachment of these cells to the underlying GBM and
through AGBM-Ab induced separation of the endothelial cell
from the underlying GBM [1—4]. Partial amelioration of the
reduction in LpA by prior complement depletion was associ-
ated strongly with prevention of the accumulation of polymor-
phonuclear leukocytes. Some endothelial separation persisted
after complement depletion, suggesting that this cellular event
could not be attributed solely to the action of and cytotoxic
products released by activated PMN. However, the contribu-
tion of the PMN to this reduction in LpA may not be solely
mechanical or anatomic. Harlan et al have provided direct
evidence in endothelial cell cultures that activated PMNs di-
rectly can cause cell lysis and cell detachment during the
inflammatory process and, presumably, this participation of the
PMN is associated with complement activation in vivo [5].
Therefore, there may be several mechanisms whereby the PMN
may have contributed to the LpA reduction so characteristic of
acute glomerular immune injury.
The AGBM-Ab utilized in the current study did produce a
significant reduction in SNGFR. However, this antibody did
not produce renal vasoconstriction and caused the decrease in
SNGFR solely via its action to reduce LpA. AGBM-Ab admin-
istration in the present study elicited glomerular hemodynamic
responses that were different from our other studies, despite the
fact that glomerular complement deposition and PMN accumu-
lation were quite similar to those observed previously [1—4],
These findings support our prior conclusions that the renal
vasoconstriction is functional in nature, does not require renal
morphologic alterations, and does not demand specific partici-
pation of the PMN. We have found that differing pools of
AGBM-Ab will nearly always result in decreases in LpA, but
the capacity of antibodies to produce renal vasoconstriction is
quite varied. This difference was fortuitous since it permitted us
to examine the effects of prior leukocyte depletion on the
immune induced reduction in LpA at a constant nephron blood
flow, thereby eliminating this factor as a potential variable.
The present study demonstrated a correlation between the
decrease in the glomerular ultrafiltration coefficient and the
infiltration of PMNs into the glomerulus and attendant
endothelial cell damage. When PMN infiltration was reduced to
less than 10% of control in the irradiated rats, LpA was
unchanged despite complement deposition in both irradiated
and non-irradiated rats after AGBM-Ab administration. If the
results of this study were analyzed alone, a reasonable conclu-
sion would be that complement activation and deposition alone
do not have a significant effect on LpA. However, our previous
examination of the effects of complement depletion [3] and our
more recent study of the effects of human C5A infusion on
glomerular dynamics [16] provide evidence that complement
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can have a direct effect on renal vascular resistances and,
possibly, LpA [16].
These results offer reasonable evidence that PMN infiltration
into the glomerular capillary produced, by some direct or
indirect mechanism, the decrease in LpA after AGBM-Ab
administration. One mechanism by which PMN infiltration and
attachment could have reduced LpA is by blockade of capillary
loops in the glomerulus, thereby reducing the effective surface
area for filtration and shunting blood flow through fewer capil-
lary channels. However, this possibility may not be solely
adequate because with a greater than 50% reduction in LpA
after AGBM-Ab administration in the control group a loss of
50% of the channels would increase blood flow appreciably to
the remaining channels and should increase the axial pressure
gradient along the capillary, a finding that was not observed in
this investigation. PMN attachment was associated with signif-
icant endothelial stripping along the GBM in the control rats. In
the irradiated rats with less PMN attachment, endothelial
stripping was lessened after AGBM-Ab administration and
these events correlated also with the changes or lack of change
in LpA. Endothelial separation from the underlying basement
membrane may create unstirred layers, allowing protein con-
centration at the basement membrane to increase above capil-
lary mean crossectional protein concentration and thereby
reducing the calculated ultrafiltration coefficient. The PMNs'
release of cytotoxic elements [5, 17—19] and the potential
alteration in the charge density of the GBM [20, 211 may have
direct effects on local capillary permeability (Lp) [21]. A
combination of these events may have contributed to the
AGBM-Ab induced decrease in LpA via migration and attach-
ment of PMNs.
The direct influences of irradiation alone and subsequent
leukocyte depletion exerted little or no effect on glomerular
dynamics in this study, despite some observed morphologic
alterations in the appearance of glomeruli. Although irradiation
did not alter glomerular hemodynamics in the control condition
prior to AGBM-Ab administration, this form of pre-treatment
may have exerted its beneficial effect by mechanisms indepen-
dent of the mechanical or anatomic effects of the PMN.
Kreisberg and coworkers have suggested a major role for
mononuclear cells that may migrate into the glomerular capil-
lary prior to the PMN and contribute to the development of
proteinuria in a nephrotoxic model [22]. These authors showed
that in this somewhat different model, whole body irradiation
and anti-lymphocyte serum reduced the number of these infil-
trating cells and reduced proteinuria. Since some radiation did
reach the kidneys, it is possible that resident glomerular cells
may have been affected and contributed to amelioration of
glomerular hemodynamic changes by a currently unknown
mechanism. It is possible also that, in addition to leukocyte
depletion, other humoral or molecular events may have been
modified or eliminated by prior irradiation.
In summary, both the physiologic measurements and mor-
phologic examination indicate that leukocyte depletion dimin-
ishes leukocyte infiltration into the glomerulus after AGBM-Ab
administration and prevents the decrease in SNGFR by elim-
inating the reduction in LpA. This study provides evidence that
leukocyte infiltration and attachment to the glomerular wall
either may reduce the effective surface area for filtration or alter
the effective glomerular permeability or a combination of these
two factors. These data suggest a major role for leukocytes and,
in particular, polymorphonuclear leukocytes in mediating the
decrease in glomerular hydraulic conductivity or glomerular
surface area in the early phase of acute immune injury.
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